Education
About Us
Working with TipRanks
Follow Us
Supriya Lifescience Limited (IN:SUPRIYA)
:SUPRIYA
SUPRIYA Stock Chart & Stats
₹737.35
-₹18.10(-2.41%)
At close: 4:00 PM EST
₹737.35
-₹18.10(-2.41%)
Day’s Range― - ―
52-Week Range₹556.85 - ₹841.70
Previous CloseN/A
Volume168.68K
Average Volume (3M)18.01K
Market Cap
₹58.84B
Enterprise Value₹57.66B
Total Cash (Recent Filing)₹791.54M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)32.3
Beta1.21
Next Earnings
Jan 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.14%
Share Statistics
EPS (TTM)6.30
Shares Outstanding80,482,800
10 Day Avg. Volume18,341
30 Day Avg. Volume18,009
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)5.91
Price to Sales (P/S)8.46
P/FCF Ratio578.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2,167.71
Revenue Forecast (FY)₹726.94B
Supriya Lifescience Limited News
SUPRIYA FAQ
What was Supriya Lifescience Limited’s price range in the past 12 months?
Supriya Lifescience Limited lowest stock price was ₹556.85 and its highest was ₹841.70 in the past 12 months.
What is Supriya Lifescience Limited’s market cap?
Supriya Lifescience Limited’s market cap is ₹58.84B.
When is Supriya Lifescience Limited’s upcoming earnings report date?
Supriya Lifescience Limited’s upcoming earnings report date is Jan 16, 2026 which is in 29 days.
How were Supriya Lifescience Limited’s earnings last quarter?
Supriya Lifescience Limited released its earnings results on Nov 12, 2025. The company reported ₹6.3 earnings per share for the quarter, beating the consensus estimate of N/A by ₹6.3.
Is Supriya Lifescience Limited overvalued?
According to Wall Street analysts Supriya Lifescience Limited’s price is currently Overvalued.
Does Supriya Lifescience Limited pay dividends?
Supriya Lifescience Limited pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.14%. See more information on Supriya Lifescience Limited dividends here
What is Supriya Lifescience Limited’s EPS estimate?
Supriya Lifescience Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Supriya Lifescience Limited have?
Supriya Lifescience Limited has 80,482,800 shares outstanding.
What happened to Supriya Lifescience Limited’s price movement after its last earnings report?
Supriya Lifescience Limited reported an EPS of ₹6.3 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.442%.
Which hedge fund is a major shareholder of Supriya Lifescience Limited?
Currently, no hedge funds are holding shares in IN:SUPRIYA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Supriya Lifescience Limited
Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, antihypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.
Technical Analysis
Aarti Drugs Limited
―
Gufic Biosciences Limited
―
Sequent Scientific Limited
―
Sun Pharma Advanced Research Co. Ltd.
―
Suven Life Sciences Limited
―